Gene Query: KCNE3

Dataset Description Geneva Score
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 67.04
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 67.04
Differentially expressed genes post knock down of lincDUSP26 54.15
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 50.21
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 42.43
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 39.39
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 32.09
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 32.09
The role of the Calcium-Sensing receptor in colorectal cancer 31.51
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 30.08
EWS-Fli and LNC regulated genes in comparison to GFP samples 29.62
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 27.69
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 23.61
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 23.61
Gene expression alterations of pancreatic intraepithlial neoplasia 22.29
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 21.79
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 21.77
Genome-wide chromatin analysis of Ewing sarcoma 21.77
Transcriptome of EBV-infected gastric cancer cell lines 19.24
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 19.1
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 18.79
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 18.59
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 17.05
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 16.65
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 15.83
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 15.83
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 15.62
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 15.07
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 14.71
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 14.68
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 14.64
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 13.95
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 13.73
Pharmacologic inhibition of STAT5 in AML 13.59
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 13.59
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 12.86
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 12.82
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 12.64
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 12.5
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 12.32
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 11.96
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 11.96
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 11.86
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 11.86
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 11.71
Clinker: visualizing fusion genes detected in RNA-seq data 11.56
Identifying the molecular mode of action of itraconazole in colorectal cancer 11.32
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 11.26
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 11.25
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 10.89
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 10.65
Transcriptional profiling of LS1034 cells treated with tepoxalin 10.54
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 10.36
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 10.28
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 10.22
Transcriptional profile in human S. haematobium infection 10.04
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 9.95
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 9.85
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 9.82
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 9.82
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 9.7
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 9.46
Transcriptomes of human monocytes after ex vivo exposure to uric acid 9.28
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 9.24
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 9.21
Intron retention induced by microsatellite expansions as a disease biomarker. 9.05
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 8.89
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 8.74
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 8.68
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 8.68
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 8.56
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 8.54
RNA seq comparison between scrambled and shGRP78 cells 8.46
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 8.37
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 8.37
CircRNAome diversity in human mature B-cells, T-cells and monocytes 8.24
RNA-seq analysis of AML cells in response to ASLAN003 8.13
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 8.09
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 8.09
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 7.91
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 7.91
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 7.77
Gene expression changes associated with resistance to tagraxofusp (SL-401) 7.56
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.53
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 7.45
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 7.04
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 6.89
WRN knockout effects upon gene expression in SW48 and OVK18 6.76
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 6.72
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 6.64
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 6.58
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 6.54
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 6.34
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 6.34
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 6.27
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 6.27
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 6.18
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 6.09
Human neutrophil genome during PMA- and E. coli encounter-induced activation 6.09
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 6.06
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 6.05
Total RNA sequencing of WT intestinal orgaonids. 5.98
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 5.88
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 5.85
NAPRT activation of macrophages 5.85
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 5.74
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 5.69
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.67
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.67
RNA Sequencing of three pairs of gastric cancer 5.65
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 5.61
Transcriptomic profiling of human peripheral blood-derived mast cells 5.58
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 5.58
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.53
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.46
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.45
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 5.36
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.36
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.36
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 5.32
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 5.2
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 5.18
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 5.17
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.15
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.15
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 5.12
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 5.08
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 5.08
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 5.07
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 5.04
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 5.03
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 5.0
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 4.99
TAF1 is critical for AE driven leukemogenesis 4.99
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 4.99
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 4.98
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 4.98
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.94
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.94
Transcriptome analysis of peripheral blood monocytes 4.93
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 4.89
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.89
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 4.86
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 4.77
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 4.73
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 4.73
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 4.7
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.66
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 4.65
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 4.63
RNA-Seq in neutrophils from Antiphospholipid Syndrome 4.6
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 4.54
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 4.47
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 4.46
Dysregulated immune system networks in war veterans with PTSD 4.44
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.43
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 4.42
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 4.34
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.25
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 4.19
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 4.18
Global transcriptome analysis of HAP1 cells 4.16
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.15
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.1
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 4.08
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 4.03
RNA-seq of YB5 cells treated with Proscillaridin A 3.98
Genome-wide identification of cancer-specific alternative splicing in circRNA 3.9
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 3.89
ZIKV infection of monocytes activates inflammasome pathways 3.88
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 3.84
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 3.84
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 3.82
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 3.82
Transcriptome of diurnal human blood neutrophils 3.73
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 3.72
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 3.68
A map of gene expression in neutrophil-like cell lines 3.65
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 3.62
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 3.59
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 3.58
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 3.55
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 3.55
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.53
Tpl-2 small molecule project 3.51
Tpl-2 and MEK small molecule inhibitors 3.51
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.51
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 3.48
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 3.48
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.47
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 3.47
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 3.47
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.45
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 3.43
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 3.43
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 3.42
oxLDL exposed trained monocytes 3.36
Transcriptomes of oxLDL exposed trained monocytes 3.36
MEIS1 regulates hematopoiesis in hPSCs 3.3
RNA seq analysis of human Fetal and adult derived Enterospheres 3.26
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 3.25
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 3.21
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.19
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 3.16
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 3.16
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 3.13
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 3.12
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 3.12
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 3.07
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.07
Effects of rFVIIIFc on human macrophages 3.05
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 3.05
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 3.02
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 3.02
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 2.99
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.98
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 2.98
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 2.91
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 2.87
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.87
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.82
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 2.78
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 2.77
Transcriptome of Stabilin-1 siRNA transfected human monocytes 2.73
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 2.72
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 2.72
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.7
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.64
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.64
Macrophage Ad5f35 PhenoMap 2.63
Human cells contain natural double-stranded RNAs with potential regulatory capacity 2.62
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.55
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.51
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 2.5
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.5
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.48
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.46
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.44
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 2.43
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 2.39
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.37
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 2.34
circNFIB suppresses lymphatic metastasis of pancreatic cancer 2.33
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.32
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.31
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 2.31
The gene expression profiles of gallbladder cancer 2.3
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 2.27
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 2.21
RNA-Seq and expression data from human adipose tissue 2.21
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.21
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 2.2
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 2.2
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 2.19
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 2.19
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 2.18
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 2.16
RNA-Seq analysis of breast cancer cells after shikonin treatment 2.15
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 2.13
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 2.12
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 2.11
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 2.09
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 2.09
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 2.09
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.09
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 2.07
Targeting MTHFD2 in Acute Myeloid Leukemia 2.06
Macrophage Ad5f35 M2 Challenge 2.05
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 2.03
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 2.0
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 2.0
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 2.0
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 1.96
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.95
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 1.94
Gene expression profile difference among renal location in a stone former 1.93
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 1.92
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 1.92
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.9
RNA-seq of stable and unstable section of human atherosclerotic plaques 1.9
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.87
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 1.84
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.84
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 1.82
Developmental stage specific chromosome architecture in human erythroid cells 1.82
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.82
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 1.81
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.79
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.78
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 1.75
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 1.75
Molecular analysis of renal cell carcinoma with unclassfied histology 1.74
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.74
U2AF1 mutations alter splice site recognition in hematological malignancies 1.74
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 1.74
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 1.73
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 1.73
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.72
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.72
Identification of renal resident macrophages across species 1.71
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 1.7
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 1.7
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 1.69
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.68
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.68
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.68
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.68
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.66
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.65
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 1.61
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 1.61
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.6
Chromatin landscape of human visceral and subcutaneous adipocytes 1.6
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.6
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 1.58
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 1.58
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.58
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.56
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.56
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.56
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.56
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.55
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.51
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 1.5
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.49
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.47
RNA-seq of SCLC PDX models treated with EP 1.47
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 1.47
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.47
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 1.46
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 1.46
Endometrial transcriptome and PGR cistrome in cycling fertile women 1.45
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 1.45
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.44
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 1.43
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 1.43
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 1.4
Aging-associated patterns in the expression of human endogenous retroviruses 1.37
LncRNA expression profiling of ischemic stroke patients 1.35
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 1.34
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 1.32
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.32
Transcription control by the ENL YEATS domain in acute leukemia 1.32
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 1.31
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 1.31
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.31
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.31
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.3
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 1.3
MicroRNA-125a-5p overexpression in human macrophages 1.29
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.25
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.25
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 1.24
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 1.24
Transcriptome wide analysis of classically and alternatively activated macrophages 1.24
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.23
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 1.22
quanTIseq: quantifying immune contexture of human tumors 1.22
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.22
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.22
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.21
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 1.21
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 1.21
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 1.2
Identification of long noncoding RNAs regulated by p53 1.2
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.18
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 1.18
Transcriptome sequencing of K-562 cells 1.17
RNA-sequencing 1.16
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.14
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.13
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.12
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.12
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 1.09
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.08
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 1.08
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.07
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 1.06
Trascriptome of thyroid cancer-induced macrophages 1.04
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.04
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.04
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.03
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 1.01
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 0.99
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.98
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 0.98
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 0.97
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.97
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.96
CUREfast: Accelerating research with families 0.93
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 0.91
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.9
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.85
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 0.84
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 0.83
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 0.83
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.83
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.82
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.82
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 0.81
A single cell reference map for human blood and tissue T cell activation 0.8
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.78
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.78
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.77
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.76
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 0.75
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 0.73
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 0.73
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.71
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.71
Microglia innatly develop within cerebral organoids 0.7
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 0.69
Single cell transcriptome of peritoneal cells 0.68
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.66
Expression analysis of the TAF1 syndrome 0.63
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.61
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 0.61
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.61
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 0.61
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.6
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.6
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.59
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.59
Transcriptomic analysis of human macrophages in 3D 0.59
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.58
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.58
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.54
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.54
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.54
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.54
The expression profiles of GBC liver metastasis 0.53
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.53
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.51
RNA-seq of CD33 KO and control HSPCs 0.5
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.5
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.49
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.48
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.47
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.47
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.47
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.45
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.44
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.44
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.42
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.42
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.41
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 0.4
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 0.4
RNA-seq in endometrial stromal tumors 0.4
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.39
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.39
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.38
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.38
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.37
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.35
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.34
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.34
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.33
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.32
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.31
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.31
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.29
Impact on erythroid progenitor type on erythroid differntiation 0.28
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.28
Transcriptome Profiling of Human Primary Monocytes 0.28
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.27
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.26
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.21
Gene expression analysis of human adenomas. 0.2
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.2
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.19
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.19
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.19
RNA-seq of primary patient AML samples 0.18
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.17
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.17
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.16
RNA sequencing of human pancreatic cancer cell lines 0.16
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.15
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.15
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.13
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.12
Specific molecular signatures underlie response to decitabine in CMML 0.1
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.1
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.1
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.1
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.1
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.08
Leucegene: AML sequencing (part 6) 0.07
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.07
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.05
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 0.05
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.05
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.02
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.01
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.01
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.0
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 0.0
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 0.0
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation